Acute Myocardial Infarction and Unstable Angina Patients With PCSK9 Inhibitor Usage Study
Acute Myocardial Infarction and Unstable Angina Patients With PCSK9 Inhibitor Usage Study
Acute coronary syndrome (ACS) is a lethal disease, reduced low-density lipoprotein (LDL) cholesterol due to inhibition of proprotein convertase subtilisin/kexin 9 (PCSK9) reduces cardiovascular events and improve cardiovascular prognosis. we assuming that PCSK9 inhibitor could bring metabolic change in serum, in order to investigate the metabolic modification, we conduct this clinical trial.
Inclusion Criteria:
Exclusion Criteria:
litangzhiming@126.com+86 18588269277
+86 13509633742